Terms: = Head and neck cancer AND ER, estrogen receptor AND Treatment
427 results:
1. Risk factors for lymph node metastasis in superficial esophageal squamous cell carcinoma.
Yu YB
World J Gastroenterol; 2024 Apr; 30(13):1810-1814. PubMed ID: 38659479
[TBL] [Abstract] [Full Text] [Related]
2. Laser therapy decreases oral leukoplakia recurrence and boosts patient comfort: a network meta-analysis and systematic review.
Luo R; Wang Y; Li R; Ma Y; Chen H; Zhang J; Shen J
BMC Oral Health; 2024 Apr; 24(1):469. PubMed ID: 38632580
[TBL] [Abstract] [Full Text] [Related]
3. Amlodipine inhibits the proliferation and migration of esophageal carcinoma cells through the induction of endoplasmic reticulum stress.
Chen YM; Yang WQ; Gu CW; Fan YY; Liu YZ; Zhao BS
World J Gastroenterol; 2024 Jan; 30(4):367-380. PubMed ID: 38313237
[TBL] [Abstract] [Full Text] [Related]
4. Effects of postoperative antioxidants on the salivary glands in patients with thyroid cancer undergoing radioactive iodine-131 treatment.
Tong H; Yue R; Fang J; Li X; Yang S; Hou Y; Wang R; Zhang B; Liu H; Wu Z; Cheng Y
Nucl Med Commun; 2024 Apr; 45(4):312-320. PubMed ID: 38312062
[TBL] [Abstract] [Full Text] [Related]
5. Higher adjuvant radioactive iodine therapy dosage helps intermediate-risk papillary thyroid carcinoma patients achieve better therapeutic effect.
Li X; Zheng H; Ma C; Ji Y; Wang X; Sun D; Meng Z; Zheng W
Front Endocrinol (Lausanne); 2023; 14():1307325. PubMed ID: 38298190
[TBL] [Abstract] [Full Text] [Related]
6. An ESR1-Related Gene Signature Identifies head and neck Squamous Cell Carcinoma with Imputed Susceptibility to Endocrine Therapy.
Almouhanna F; Hess J
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38279245
[TBL] [Abstract] [Full Text] [Related]
7. Long-term outcomes after non-curative endoscopic resection for esophageal squamous cell carcinoma followed by additional chemoradiotherapy.
Cho H; Abe S; Nonaka S; Suzuki H; Yoshinaga S; Okuma K; Yamamoto S; Daiko H; Kato K; Sekine S; Boku N; Saito Y
Dis Esophagus; 2024 Apr; 37(5):. PubMed ID: 38266034
[TBL] [Abstract] [Full Text] [Related]
8. RCN1 deficiency inhibits oral squamous cell carcinoma progression and THP-1 macrophage M2 polarization.
Liu H; Guo H; Wu Y; Hu Q; Hu G; He H; Yin Y; Nan X; Lin G; Han J; Zhao R; Liu Y
Sci Rep; 2023 Dec; 13(1):21488. PubMed ID: 38057406
[TBL] [Abstract] [Full Text] [Related]
9. CDK4 phosphorylation status and rational use for combining CDK4/6 and BRAF/MEK inhibition in advanced thyroid carcinomas.
Pita JM; Raspé E; Coulonval K; Decaussin-Petrucci M; Tarabichi M; Dom G; Libert F; Craciun L; Andry G; Wicquart L; Leteurtre E; Trésallet C; Marlow LA; Copland JA; Durante C; Maenhaut C; Cavaco BM; Dumont JE; Costante G; Roger PP
Front Endocrinol (Lausanne); 2023; 14():1247542. PubMed ID: 37964967
[TBL] [Abstract] [Full Text] [Related]
10. Acetylshikonin induces apoptosis through the endoplasmic reticulum stress-activated PERK/eIF
Yuan YJ; Liu S; Yang H; Xu JL; Zhai J; Jiang HM; Sun B
J Cell Mol Med; 2024 Jan; 28(1):e18030. PubMed ID: 37929884
[TBL] [Abstract] [Full Text] [Related]
11. Usefulness of second 131I treatment in biochemical persistent differentiated thyroid cancer patients.
Gambale C; Prete A; Contartese L; Torregrossa L; Bianchi F; Molinaro E; Materazzi G; Elisei R; Matrone A
Eur Thyroid J; 2023 Dec; 12(6):. PubMed ID: 37855417
[TBL] [Abstract] [Full Text] [Related]
12. BRAF
Cao J; Chen B; Zhu X; Sun Y; Li X; Zhang W; Wang X
Endocrine; 2024 Apr; 84(1):160-170. PubMed ID: 37851243
[TBL] [Abstract] [Full Text] [Related]
13. Stimulated thyroglobulin and pre-ablation antithyroglobulin antibody products can predict the response to radioiodine therapy of TgAb-positive differentiated thyroid cancer patients: a retrospective study.
Han N; Lu C; Li J; Wang C; Zhao Z; Zhang Y; Liu X; Si Z; Wang G; Wang Z; Li F; Wang X
Front Endocrinol (Lausanne); 2023; 14():1222470. PubMed ID: 37810895
[TBL] [Abstract] [Full Text] [Related]
14. Hypoxia-induced TMTC3 expression in esophageal squamous cell carcinoma potentiates tumor angiogenesis through Rho GTPase/STAT3/VEGFA pathway.
Yuan H; Zhao Z; Xu J; Zhang R; Ma L; Han J; Zhao W; Guo M; Song Y
J Exp Clin Cancer Res; 2023 Sep; 42(1):249. PubMed ID: 37752569
[TBL] [Abstract] [Full Text] [Related]
15. estrogen receptor β affects hypoxia response in colorectal cancer cells.
Rawłuszko-Wieczorek AA; Lipowicz J; Nowacka M; Ostrowska K; Pietras P; Blatkiewicz M; Ruciński M; Jagodziński PP; Nowicki M
Biochim Biophys Acta Mol Basis Dis; 2024 Jan; 1870(1):166894. PubMed ID: 37748565
[TBL] [Abstract] [Full Text] [Related]
16. Random Forest for Predicting treatment Response to Radioiodine and Thyrotropin Suppression Therapy in Patients With Differentiated Thyroid cancer But Without Structural Disease.
Sa R; Yang T; Zhang Z; Guan F
Oncologist; 2024 Jan; 29(1):e68-e80. PubMed ID: 37669005
[TBL] [Abstract] [Full Text] [Related]
17. Long-term prognostic analysis of children and adolescents with differentiated thyroid carcinoma based on therapeutic response to initial radioiodine therapy.
Wang C; Lu G; Li Y; Liu X; Wang G; Lu C; Li J; Luo Q; Zhang Q; Sun M; Wang X; Wang R
Front Endocrinol (Lausanne); 2023; 14():1217092. PubMed ID: 37600705
[TBL] [Abstract] [Full Text] [Related]
18. Predictive and prognostic markers from endoscopic ultrasound with biopsies during definitive chemoradiation therapy in esophageal squamous cell carcinoma.
Du Q; Wu X; Zhang K; Cao F; Zhao G; Wei X; Guo Z; Li Y; Dong J; Zhang T; Zhang W; Wang P; Chen X; Pang Q
BMC Cancer; 2023 Jul; 23(1):681. PubMed ID: 37474893
[TBL] [Abstract] [Full Text] [Related]
19. Endoscopic resection for local residual or recurrent cancer after definitive chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma.
Tani Y; Ishihara R; Matsuura N; Okubo Y; Kawakami Y; Sakurai H; Nakamura T; Matsueda K; Miyake M; Shichijo S; Maekawa A; Kanesaka T; Yamamoto S; Takeuchi Y; Higashino K; Uedo N; Michida T
Sci Rep; 2023 Jun; 13(1):10451. PubMed ID: 37380631
[TBL] [Abstract] [Full Text] [Related]
20. Quantitative parameters derived from dual-energy computed tomography for the preoperative prediction of early recurrence in patients with esophageal squamous cell carcinoma.
Liu Y; Cheng F; Wang L; Du L; Shen H; Wang X; Zeng Z; Liu D; Tao J; Wu J; Zhang J
Eur Radiol; 2023 Nov; 33(11):7419-7428. PubMed ID: 37314470
[TBL] [Abstract] [Full Text] [Related]
[Next]
